溶血
生物医学工程
纤维蛋白
人类血液
体外
体内
蛋白质吸附
生物材料
血栓
血小板
凝结
血小板粘附
化学
材料科学
吸附
医学
免疫学
外科
生物化学
生物
有机化学
生物技术
精神科
生理学
作者
Marbod Weber,Heidrun Steinle,Sonia Golombek,Ludmilla Hann,Christian Schlensak,Hans Peter Wendel,Meltem Avci‐Adali
标识
DOI:10.3389/fbioe.2018.00099
摘要
Hemocompatibility of blood-contacting biomaterials is one of the most important criteria for their successful in vivo applicability. Thus, extensive in vitro analyses according to ISO 10993-4 are required prior to clinical applications. In this review, we summarize essential aspects regarding the evaluation of the hemocompatibility of biomaterials and the required in vitro analyses for determining the blood compatibility. Static, agitated, or shear flow models are used to perform hemocompatibility studies. Before and after the incubation of the test material with fresh human blood, hemolysis, cell counts, and the activation of platelets, leukocytes, coagulation and complement system are analyzed. Furthermore, the surface of biomaterials are evaluated concerning attachment of blood cells, adsorption of proteins, and generation of thrombus and fibrin networks.
科研通智能强力驱动
Strongly Powered by AbleSci AI